Quark announces issue of U.S. patent for novel treatment of lung transplantation associated injury

December 9th, 2015

Quark announces patent approval for Methods for treating eye disorders

September 1st, 2015

Quark announces patent approval for Compositions and methods for treatment of ear disorders

July 28th, 2015

Quark announces patent approval for therapeutic uses of inhibitors of RTP801

June 16th, 2015

Quark announces patent approval for double stranded RNA compounds to RhoA and use thereof

June 2nd, 2015

Quark announces patent approval for oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases

April 14th, 2015

Quark announces patent approval for Methods for delivery of siRNA to the spinal cord and therapies arising therefrom

December 2nd, 2014

Quark announces Patent Approval for Oligonucleotide compounds comprising non-nucleotide overhangs

October 14th, 2014

Quark announces patent approval for Sirna compounds comprising terminal substitutions

August 5th, 2014